We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Kaneka Eurogentec

News List

Kaneka Eurogentec Expands Capabilities contractpharma
February 18, 2021
Kaneka Eurogentec, a custom service and FDA inspected contract development and manufacturing organization (CDMO), received GMP accreditation by the Belgian ministry of health for the GMP manufacturing of messenger RNA (mRNA).
INOVIO Expands Global Manufacturing Consortium For Its COVID-19 Vaccine Candidate INO-4800 With Addition of Kaneka Eurogentec S.A. prnasia
December 04, 2020
INOVIO announced the execution of an agreement with Kaneka Eurogentec S.A., an affiliate of Kaneka Corporation, for Eurogentec to manufacture INOVIO's COVID-19 vaccine candidate INO-4800 at their industry-leading GMP plasmid production scales.